HJLI Stock Price, Chart, Stats & News

Hancock Jaffe Laboratories
Save
98.32M
Market cap
–
Current P/E
–
Forward P/E
HJLI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 0.13% |
ROA | -109.61% |
ROE | -101.31% |
D/E | 0.03x |
Interest coverage ratio | – |
HJLI valuation
P/E | – |
P/S | – |
P/B | 7.71x |
P/CF | -13.44x |
P/FCF | -6.31x |
P/OCF | -13.44x |
PEG | 0.30x |
EV multiple | -3.01x |
About
Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees.
Similar securities
Based on sector and market capitalization
Report issue











